1. Home
  2. SVII vs DERM Comparison

SVII vs DERM Comparison

Compare SVII & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVII
  • DERM
  • Stock Information
  • Founded
  • SVII 2021
  • DERM 2014
  • Country
  • SVII United States
  • DERM United States
  • Employees
  • SVII N/A
  • DERM N/A
  • Industry
  • SVII Blank Checks
  • DERM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVII Finance
  • DERM Health Care
  • Exchange
  • SVII Nasdaq
  • DERM Nasdaq
  • Market Cap
  • SVII 111.1M
  • DERM 116.8M
  • IPO Year
  • SVII 2022
  • DERM 2021
  • Fundamental
  • Price
  • SVII $11.22
  • DERM $4.68
  • Analyst Decision
  • SVII
  • DERM Strong Buy
  • Analyst Count
  • SVII 0
  • DERM 3
  • Target Price
  • SVII N/A
  • DERM $9.50
  • AVG Volume (30 Days)
  • SVII 74.3K
  • DERM 109.1K
  • Earning Date
  • SVII 01-01-0001
  • DERM 11-12-2024
  • Dividend Yield
  • SVII N/A
  • DERM N/A
  • EPS Growth
  • SVII 13.16
  • DERM N/A
  • EPS
  • SVII 0.36
  • DERM N/A
  • Revenue
  • SVII N/A
  • DERM $57,771,000.00
  • Revenue This Year
  • SVII N/A
  • DERM N/A
  • Revenue Next Year
  • SVII N/A
  • DERM $36.49
  • P/E Ratio
  • SVII $31.11
  • DERM N/A
  • Revenue Growth
  • SVII N/A
  • DERM N/A
  • 52 Week Low
  • SVII $10.81
  • DERM $2.85
  • 52 Week High
  • SVII $11.70
  • DERM $8.10
  • Technical
  • Relative Strength Index (RSI)
  • SVII 39.53
  • DERM 35.33
  • Support Level
  • SVII $11.20
  • DERM $4.88
  • Resistance Level
  • SVII $11.24
  • DERM $5.19
  • Average True Range (ATR)
  • SVII 0.01
  • DERM 0.29
  • MACD
  • SVII 0.01
  • DERM -0.07
  • Stochastic Oscillator
  • SVII 40.00
  • DERM 10.94

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: